{"news_desk": "National", "print_page": "16", "section_name": "Health", "subsection_name": null, "byline": {"contributor": "Alain Delaqu\u00e9ri\u00e8re contributed reporting from New York.", "original": "By SABRINA TAVERNISE", "person": [{"rank": 1, "role": "reported", "firstname": "Sabrina", "organization": "", "lastname": "TAVERNISE"}]}, "abstract": "Nomination of clinical researcher Dr Robert M Califf to lead the Food and Drug Administration draws questions about his connections to drug industry and past ambivalence towards regulation; supporters defend nominee's talent and integrity; government claims it implemented thorough screening for conflicts of interest.", "type_of_material": "News", "word_count": "1332", "lead_paragraph": "Dr. Robert Califf, a cardiologist and renowned clinical researcher, has deeper ties to the pharmaceutical industry than any F.D.A. commissioner in recent memory.", "pub_date": "2015-09-20T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "F.D.A. Nominee Califf\u2019s Ties to Drug Makers Worry Some", "print_headline": "F.D.A. Nominee&#8217;s Research Is Praised, but Ties to Industry Worry Some"}, "snippet": "Dr. Robert Califf, a cardiologist and renowned clinical researcher, has deeper ties to the pharmaceutical industry than any F.D.A. commissioner in recent memory.", "multimedia": [{"height": 126, "url": "images/2015/09/20/nyregion/20FDA-web/20FDA-web-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/09/20/nyregion/20FDA-web/20FDA-web-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 400, "url": "images/2015/09/20/nyregion/20FDA-web/20FDA-web-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2015/09/20/nyregion/20FDA-web/20FDA-web-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/09/20/nyregion/20FDA-web/20FDA-web-thumbStandard-v2.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/09/20/nyregion/20FDA-web/20FDA-web-thumbStandard-v2.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/09/20/health/fda-nominee-califfs-ties-to-drug-industry-raise-questions.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Califf, Robert M", "name": "persons"}, {"rank": "2", "is_major": "Y", "value": "Food and Drug Administration", "name": "organizations"}, {"rank": "3", "is_major": "Y", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "4", "is_major": "Y", "value": "Conflicts of Interest", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Clinical Trials", "name": "subject"}, {"rank": "6", "is_major": "N", "value": "Health and Human Services Department", "name": "organizations"}], "blog": [], "_id": "55fd716938f0d86e9cb6103e", "source": "The New York Times"}